JP2014532636A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014532636A5 JP2014532636A5 JP2014537693A JP2014537693A JP2014532636A5 JP 2014532636 A5 JP2014532636 A5 JP 2014532636A5 JP 2014537693 A JP2014537693 A JP 2014537693A JP 2014537693 A JP2014537693 A JP 2014537693A JP 2014532636 A5 JP2014532636 A5 JP 2014532636A5
- Authority
- JP
- Japan
- Prior art keywords
- treatment
- group
- medicament
- virus
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CP(*)(NC(*)C(O*)=O)=O Chemical compound CP(*)(NC(*)C(O*)=O)=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1159622A FR2981650B1 (fr) | 2011-10-24 | 2011-10-24 | Analogues de nucleosides pour le traitement d'une infection virale et methode d'evaluation de la sensibilite audit traitement |
| FR1159622 | 2011-10-24 | ||
| PCT/FR2012/052433 WO2013060980A1 (fr) | 2011-10-24 | 2012-10-23 | Analogues de nucleosides pour le traitement d'une infection virale, et methode d'evaluation de la sensibilite audit traitement |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014532636A JP2014532636A (ja) | 2014-12-08 |
| JP2014532636A5 true JP2014532636A5 (OSRAM) | 2015-12-03 |
Family
ID=47221470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537693A Pending JP2014532636A (ja) | 2011-10-24 | 2012-10-23 | ウイルス感染の処置のためのヌクレオシドアナログおよび該処置に対する感受性を評価するための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9181294B2 (OSRAM) |
| EP (1) | EP2771344B1 (OSRAM) |
| JP (1) | JP2014532636A (OSRAM) |
| CA (1) | CA2849969A1 (OSRAM) |
| FR (1) | FR2981650B1 (OSRAM) |
| WO (1) | WO2013060980A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11311545B2 (en) | 2014-10-09 | 2022-04-26 | Board Of Regents Of The University Of Nebraska | Compositions and methods for the delivery of therapeutics |
| US11839623B2 (en) | 2018-01-12 | 2023-12-12 | Board Of Regents Of The University Of Nebraska | Antiviral prodrugs and formulations thereof |
| US11458136B2 (en) | 2018-04-09 | 2022-10-04 | Board Of Regents Of The University Of Nebraska | Antiviral prodrugs and formulations thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4924624A (en) * | 1987-10-22 | 1990-05-15 | Temple University-Of The Commonwealth System Of Higher Education | 2,',5'-phosphorothioate oligoadenylates and plant antiviral uses thereof |
| GB8921469D0 (en) * | 1989-09-22 | 1989-11-08 | Erba Carlo Spa | 5'-alkylphosphonylnucleosides as antivirals |
| OA09370A (en) * | 1990-06-21 | 1992-09-15 | Patrick T Prendergast Irlande | Administering particular compounds against various parasites, mycoplasmas, other indications and other infections. |
| US20030008841A1 (en) * | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
| MXPA06010075A (es) * | 2004-03-05 | 2007-04-10 | Cambridge Biotechnology Ltd | Compuestos terapeuticos. |
-
2011
- 2011-10-24 FR FR1159622A patent/FR2981650B1/fr not_active Expired - Fee Related
-
2012
- 2012-10-23 WO PCT/FR2012/052433 patent/WO2013060980A1/fr not_active Ceased
- 2012-10-23 US US14/354,044 patent/US9181294B2/en not_active Expired - Fee Related
- 2012-10-23 CA CA2849969A patent/CA2849969A1/fr not_active Abandoned
- 2012-10-23 JP JP2014537693A patent/JP2014532636A/ja active Pending
- 2012-10-23 EP EP12790609.7A patent/EP2771344B1/fr not_active Not-in-force
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7508501B2 (ja) | ヌクレオチドおよびヌクレオシド組成物ならびにこれらに関連する使用 | |
| JP7786743B2 (ja) | ４’－ハロゲン含有ヌクレオチドおよびヌクレオシド治療組成物ならびにそれらに関連する使用 | |
| CA2972014A1 (en) | Fused pyrimidine compounds for the treatment of hiv | |
| JP6220484B1 (ja) | フィロウイルス科ウイルス感染症を処置するための方法 | |
| JP2013056886A5 (OSRAM) | ||
| JP2016529324A5 (OSRAM) | ||
| JP2013518107A5 (OSRAM) | ||
| JP2016515128A5 (OSRAM) | ||
| JP2018519343A5 (OSRAM) | ||
| ME02400B (me) | Policiklična karbamoilpiridonska jedinjenja i njihova farmaceutska upotreba | |
| JP2006524660A5 (OSRAM) | ||
| JP2019500387A5 (OSRAM) | ||
| MA38138A1 (fr) | Dérivés inédits de quinolone | |
| JP2019526596A5 (OSRAM) | ||
| JP2017531619A5 (OSRAM) | ||
| JP2019510027A5 (OSRAM) | ||
| WO2017106710A1 (en) | Nucleotide and nucleoside therapeutic compositions and uses related thereto | |
| JP7129703B2 (ja) | アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用 | |
| JP2016513113A5 (OSRAM) | ||
| JP2015521156A5 (OSRAM) | ||
| JP2018529714A (ja) | Ｈｉｖの処置のための化合物および組合せ物 | |
| JP2024517807A (ja) | ヌクレオチド及びヌクレオシド治療組成物、組合せ、並びにそれらに関連する使用 | |
| JP2022509763A5 (OSRAM) | ||
| US20040157793A1 (en) | Modified nucleosides as antiviral agents | |
| JP2014532636A (ja) | ウイルス感染の処置のためのヌクレオシドアナログおよび該処置に対する感受性を評価するための方法 |